Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus.
<h4>Background</h4>Cancer stem cells/initiating cells (CSC/CIC), are thought to exist as a small population in malignant tissues. They are resistant to conventional cancer treatments and possibly underlie post-treatment relapse. The CIC population can be targeted with capsid modified onc...
Guardado en:
Autores principales: | Laura Ahtiainen, Cristina Mirantes, Tiina Jahkola, Sophie Escutenaire, Iulia Diaconu, Pamela Osterlund, Anna Kanerva, Vincenzo Cerullo, Akseli Hemminki |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e980cd7d5ead401aa6fc1c566dc14e69 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131I.
por: Maria Rajecki, et al.
Publicado: (2012) -
Calcium gluconate in phosphate buffered saline increases gene delivery with adenovirus type 5.
por: Marko T Ahonen, et al.
Publicado: (2010) -
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses.
por: Anna Kanerva, et al.
Publicado: (2008) -
Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropism.
por: Anniina Koski, et al.
Publicado: (2013) -
Anti-tumor activity of a miR-199-dependent oncolytic adenovirus.
por: Elisa Callegari, et al.
Publicado: (2013)